Ebro Foods, S.A. (LON:0NYH)

Revance Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	264.74	249.89	329.99	184.95	539.24	210.49
Short-Term Investments	4.96	7.56	5.34	1.87	2.13	2.05
Cash & Short-Term Investments	269.7	257.45	335.33	186.82	541.36	212.54
Cash Growth	-29.68%	-23.23%	79.49%	-65.49%	154.71%	-15.99%
Accounts Receivable	431.72	437.75	424.7	458.62	387.3	427.45
Other Receivables	57.89	92.11	79.23	101.9	87.2	81.06
Receivables	489.76	530.12	504.16	560.76	476.64	509.82
Inventory	859.86	866.81	775.29	911.12	702.7	578.28
Other Current Assets	20.91	12.83	12.3	10.48	12.61	157.58
Total Current Assets	1,640	1,667	1,627	1,669	1,733	1,458
Property, Plant & Equipment	947.25	970.23	906.66	879.09	848.06	934.04
Long-Term Investments	56.56	54.2	49.27	45.41	45.35	47.33
Goodwill	783.19	820.81	798.38	807.07	809.36	1,062
Other Intangible Assets	417.52	439.61	425.06	429.43	434.29	449.36
Long-Term Deferred Tax Assets	40.55	45.09	44.88	48.79	46.27	62
Long-Term Deferred Charges	-	0.03	0.03	0.05	0.06	-
Other Long-Term Assets	11.69	11.94	18.33	19.38	19.4	19.45
Total Assets	3,899	4,011	3,872	3,900	3,939	4,036
Accounts Payable	419.04	354.45	341.49	359.82	345.64	386.02
Accrued Expenses	20.5	66.16	57.94	53.75	61.51	86.03
Current Portion of Long-Term Debt	376.88	328.39	473.88	196.44	260.77	582.35
Current Portion of Leases	10.16	10.07	9.16	8.69	8.93	11.42
Current Income Taxes Payable	24.06	27.92	17.68	14.36	37.45	49.88
Other Current Liabilities	349.11	357.28	292.1	236.81	209.44	67
Total Current Liabilities	1,200	1,144	1,192	869.87	923.75	1,183
Long-Term Debt	133.53	128.37	101	479.52	523.89	310.75
Long-Term Leases	46.23	47.74	50.37	52.34	55.22	68.53
Long-Term Unearned Revenue	19.59	15.3	15.8	10.92	10.33	11.44
Long-Term Deferred Tax Liabilities	234.55	248.33	228.49	227.29	222.22	242.92
Other Long-Term Liabilities	44.77	44.13	39.13	36.81	34.94	205.07
Total Liabilities	1,694	1,646	1,649	1,702	1,805	2,078
Common Stock	92.32	92.32	92.32	92.32	92.32	92.32
Additional Paid-In Capital	0	0	0	0	0	0
Retained Earnings	2,023	2,021	1,965	1,931	1,901	1,833
Comprehensive Income & Other	49.74	216.35	127.78	140.82	108.16	2.33
Total Common Equity	2,165	2,330	2,185	2,164	2,102	1,927
Minority Interest	39.31	35.53	36.97	33.84	31.56	30.45
Shareholders' Equity	2,205	2,365	2,222	2,198	2,133	1,958
Total Liabilities & Equity	3,899	4,011	3,872	3,900	3,939	4,036
Total Debt	566.8	514.57	634.41	736.99	848.81	973.05
Net Cash (Debt)	-297.11	-257.12	-299.08	-550.16	-307.45	-760.51
Net Cash Per Share	-1.93	-1.67	-1.94	-3.58	-2.00	-4.94
Filing Date Shares Outstanding	153.87	153.87	153.87	153.87	153.87	153.87
Total Common Shares Outstanding	153.87	153.87	153.87	153.87	153.87	153.87
Working Capital	440.5	522.95	434.83	799.31	809.56	275.52
Book Value Per Share	14.07	15.14	14.20	14.07	13.66	12.53
Tangible Book Value	964.65	1,069	961.72	927.93	857.98	416.39
Tangible Book Value Per Share	6.27	6.95	6.25	6.03	5.58	2.71
Land	-	126.4	122.54	120.84	117.2	130.82
Buildings	-	412.8	381.71	381.7	354.54	415.54
Machinery	-	1,258	1,133	1,064	989.25	1,211
Construction In Progress	-	96.67	91.96	81.66	79.05	64.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.